Hunan Hansen Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Hunan Hansen Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Hunan Hansen Pharmaceutical Co Ltd (002412) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥52.51 Million ≈ $7.68 Million USD) by net assets (CN¥2.26 Billion ≈ $330.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Hunan Hansen Pharmaceutical Co Ltd (2007–2025)
Cash flow conversion efficiency of Hunan Hansen Pharmaceutical Co Ltd from 2007 to 2025. This chart illustrates how Hunan Hansen Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Hunan Hansen Pharmaceutical Co Ltd for real-time trading data and today's change.
Hunan Hansen Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Hunan Hansen Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Hunan Hansen Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hunan Hansen Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Hunan Hansen Pharmaceutical Co Ltd market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Merry Electronics Co Ltd
TW:2439
|
-0.111x |
|
Saha Pathanapibul Public Company Limited
BK:SPC
|
0.008x |
|
Atlanta Braves Holdings, Inc. Series A Common Stock
NASDAQ:BATRA
|
-0.003x |
|
G-Tech Optoelectronics Corp
TW:3149
|
-0.055x |
|
Shenzhen Kaizhong Precision Technology Co Ltd
SHE:002823
|
0.082x |
|
BEIJ.JINGNENG CL.ERG.HYC1
F:BJ6
|
N/A |
|
Shenzhen Liande Automatic Equipment Co Ltd
SHE:300545
|
-0.012x |
|
Thai Stanley Electric Public Company Limited
BK:STANLY
|
0.026x |
Annual Cash Flow Conversion Efficiency for Hunan Hansen Pharmaceutical Co Ltd (2007–2025)
The table below shows the annual cash flow conversion efficiency of Hunan Hansen Pharmaceutical Co Ltd from 2007 to 2025. Review how much free cash does Hunan Hansen Pharmaceutical Co Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.38 Billion ≈ $348.40 Million |
CN¥245.38 Million ≈ $35.91 Million |
0.103x | +73.63% |
| 2024-12-31 | CN¥2.20 Billion ≈ $322.42 Million |
CN¥130.78 Million ≈ $19.14 Million |
0.059x | -27.60% |
| 2023-12-31 | CN¥1.96 Billion ≈ $287.25 Million |
CN¥160.95 Million ≈ $23.55 Million |
0.082x | +7.99% |
| 2022-12-31 | CN¥1.89 Billion ≈ $277.17 Million |
CN¥143.81 Million ≈ $21.04 Million |
0.076x | -37.76% |
| 2021-12-31 | CN¥1.74 Billion ≈ $254.95 Million |
CN¥212.54 Million ≈ $31.10 Million |
0.122x | +19.95% |
| 2020-12-31 | CN¥1.59 Billion ≈ $233.36 Million |
CN¥162.19 Million ≈ $23.73 Million |
0.102x | -5.76% |
| 2019-12-31 | CN¥1.53 Billion ≈ $223.88 Million |
CN¥165.11 Million ≈ $24.16 Million |
0.108x | -32.36% |
| 2018-12-31 | CN¥1.36 Billion ≈ $199.50 Million |
CN¥217.52 Million ≈ $31.83 Million |
0.160x | +81.50% |
| 2017-12-31 | CN¥1.22 Billion ≈ $178.41 Million |
CN¥107.18 Million ≈ $15.68 Million |
0.088x | -31.35% |
| 2016-12-31 | CN¥1.26 Billion ≈ $184.16 Million |
CN¥161.16 Million ≈ $23.58 Million |
0.128x | +152.48% |
| 2015-12-31 | CN¥1.25 Billion ≈ $183.42 Million |
CN¥63.57 Million ≈ $9.30 Million |
0.051x | -31.23% |
| 2014-12-31 | CN¥1.15 Billion ≈ $168.75 Million |
CN¥85.05 Million ≈ $12.44 Million |
0.074x | +7.35% |
| 2013-12-31 | CN¥1.11 Billion ≈ $162.08 Million |
CN¥76.09 Million ≈ $11.13 Million |
0.069x | -33.85% |
| 2012-12-31 | CN¥965.11 Million ≈ $141.23 Million |
CN¥100.23 Million ≈ $14.67 Million |
0.104x | +70.44% |
| 2011-12-31 | CN¥883.65 Million ≈ $129.31 Million |
CN¥53.84 Million ≈ $7.88 Million |
0.061x | +157.83% |
| 2010-12-31 | CN¥898.82 Million ≈ $131.53 Million |
CN¥21.24 Million ≈ $3.11 Million |
0.024x | -89.66% |
| 2009-12-31 | CN¥179.51 Million ≈ $26.27 Million |
CN¥41.02 Million ≈ $6.00 Million |
0.228x | -12.30% |
| 2008-12-31 | CN¥130.26 Million ≈ $19.06 Million |
CN¥33.94 Million ≈ $4.97 Million |
0.261x | -39.43% |
| 2007-12-31 | CN¥87.77 Million ≈ $12.84 Million |
CN¥37.75 Million ≈ $5.52 Million |
0.430x | -- |
About Hunan Hansen Pharmaceutical Co Ltd
Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers medications for digestive, cardiovascular, cerebrovascular, and urological diseases, as well as for traumatology and diagnostic applications. It provides its products in various forms, including injections, mixtures, tablets, capsules, granu… Read more